Long-Term Basic Research, Evaluation Technologies, Customer-Focused Products, and New Product R&D
First written in FY2016. 26 of 30 entries say "Restated". Latest entry: FY2026.
51 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the fiscal year, our technical research institute primarily conducted R&D on refractories and fine ceramics, while Isolite Industry's technical research institute conducted R&D on insulation materials. The work focused on (1) basic research from a long-term perspective, (2) research into evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory and insulation technologies. R&D expenses for the fiscal year totaled ¥1,700 million.」
The scope of R&D was expanded to refractories, fine ceramics and insulation materials, while the four existing objectives were continued. R&D expenses totaled ¥1,700 million. - FY2025AdvancedAnnual report
「As a result, total R&D expenses for the current consolidated fiscal year were ¥1,589 million, comprising ¥1,222 million for the refractory segment, ¥365 million for the insulation materials segment and ¥1 million for the advanced equipment segment.」
The company continued its longstanding objectives of basic research, evaluation technologies, products addressing customer needs and new-product development, increasing R&D expenses from ¥1,548 million in the previous fiscal year to ¥1,589 million. - FY2024AdvancedAnnual report
「During the current consolidated fiscal year, the Company's Technical Research Institute primarily conducted R&D related to refractories, focusing on (1) basic research from a long-term perspective, (2) research into refractory evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory technologies. As a result, total R&D expenses for the current consolidated fiscal year were ¥1,548 million, comprising ¥1,194 million for the refractory business, ¥353 million for the insulation materials business and ¥1 million for the ceramics business.」
The company continued its four longstanding R&D objectives while increasing R&D expenses to ¥1,548 million. - FY2024-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥780 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed first-half R&D expenses of ¥780 million. - FY2024-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥394 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed first-quarter R&D expenses of ¥394 million. - FY2023-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥1,022 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥1,022 million for the nine months ended the third quarter. - FY2023-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥683 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥683 million for the first half of the current cumulative consolidated period. - FY2023-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥305 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed first-quarter R&D expenses of ¥305 million. - FY2022RestatedAnnual report
「During the current consolidated fiscal year, the Company's Technical Research Institute primarily conducted R&D related to refractories, focusing on (1) basic research from a long-term perspective, (2) research into refractory evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory technologies. As a result, total R&D expenses for the current consolidated fiscal year were ¥1,244 million, all related to the refractory and related products business.」
The company continued its four longstanding R&D objectives and recorded R&D expenses of ¥1,244 million. - FY2022-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥968 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥968 million for the nine months ended the third quarter. - FY2022-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥610 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed first-half R&D expenses of ¥610 million. - FY2022-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥296 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed first-quarter R&D expenses of ¥296 million. - FY2021RestatedAnnual report
「During the current consolidated fiscal year, the Company's Technical Research Institute primarily conducted R&D related to refractories, focusing on (1) basic research from a long-term perspective, (2) research into refractory evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory technologies. As a result, total R&D expenses for the current consolidated fiscal year were ¥1,151 million, all related to the refractory and related products business.」
The company continued its four longstanding R&D objectives and disclosed R&D expenses of ¥1,151 million for the year. - FY2021-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥887 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥887 million for the third quarter of the current cumulative consolidated period. - FY2021-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥585 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥585 million for the second quarter of the current cumulative consolidated period. - FY2021-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥296 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥296 million for the first quarter of the current cumulative consolidated period. - FY2020-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥783 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥783 million for the nine months ended the third quarter. - FY2020-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥503 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed first-half R&D expenses of ¥503 million. - FY2020-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥257 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥257 million for the first quarter of the current cumulative consolidated period. - FY2019-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥763 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥763 million for the nine months ended the third quarter. - FY2019-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥502 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed first-half R&D expenses of ¥502 million. - FY2019-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥247 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥247 million for the first quarter of the current cumulative consolidated period. - FY2018RestatedAnnual report
「During the current consolidated fiscal year, the Company's Technical Research Institute primarily conducted R&D related to refractories, focusing on (1) basic research from a long-term perspective, (2) research into refractory evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory technologies. As a result, total R&D expenses for the current consolidated fiscal year were ¥1,007 million, all related to the refractory and related products business.」
The company continued its four longstanding R&D objectives and disclosed R&D expenses of ¥1,007 million for the year. - FY2018-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥753 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥753 million for the nine months ended the third quarter. - FY2018-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥495 million. There were no material changes in the status of the Group's R&D activities during the period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥495 million for the first half of the current cumulative consolidated period. - FY2018-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥248 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and disclosed R&D expenses of ¥248 million for the quarter. - FY2017-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the third quarter of the current cumulative consolidated period were ¥752 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥752 million for the nine months ended the third quarter. - FY2017-Q2RestatedAnnual report
「The Group's total R&D activity expenses for the second quarter of the current cumulative consolidated period were ¥502 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed first-half R&D expenses of ¥502 million. - FY2017-Q1RestatedAnnual report
「The Group's total R&D activity expenses for the first quarter of the current cumulative consolidated period were ¥249 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥249 million for the quarter. - FY2016First statedAnnual report
「We primarily conduct R&D related to refractories, focusing on (1) basic research from a long-term perspective, (2) research into refractory evaluation technologies, including equipment development, (3) product development to meet customer needs, and (4) development of new products applying refractory technologies.」
R&D expenses totaled ¥980 million, all of which was allocated to the refractory and related products business.